Stay updated on Venetoclax and Dinaciclib in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.

Latest updates to the Venetoclax and Dinaciclib in AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page revision indicator was updated from v3.6.2 to v3.6.3, signaling a minor update to the ClinicalTrials.gov study page.SummaryDifference0.0%

- Check18 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing Revision: v3.6.0. This indicates a recent site release.SummaryDifference0.0%

- Check32 days agoChange DetectedThe study page now states that no participants are being recruited and adds new help/navigation sections such as How to Read a Study Record, Common Questions, and How to Join a Study, along with an Intervention/Treatment heading. The revision tag was updated to v3.6.0 and the older v3.5.5 tag was removed.SummaryDifference0.5%

- Check39 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5 on the page, indicating a minor behind-the-scenes update to the study record. This change represents an updated page version rather than a modification to the study data or publicly visible content.SummaryDifference0.1%

- Check61 days agoChange DetectedA new revision tag Revision: v3.5.4 is displayed, replacing Revision: v3.5.3, indicating a platform release update. This change does not modify the study data or how users access the page.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page’s interface/version footer was updated from Revision v3.5.2 to v3.5.3, reflecting a software release rather than any change to the clinical study details.SummaryDifference0.1%

Stay in the know with updates to Venetoclax and Dinaciclib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.